Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer

Sponsor
Japan Multinational Trial Organization
Study ID
NCT00104793
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy, such as irinotecan and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving irinotecan together with carboplatin may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving irinotecan together with carboplatin works in treating patients with newly diagnosed extensive-stage small cell lung cancer.

Key Dates

Start date
Jun 30, 2003
Status verified
Oct 2007
Primary completion
Feb 28, 2007
Completion
Nov 30, 2008

Study Design

Enrollment
55 participants (estimated)
Primary purpose
TREATMENT

Primary Outcome Measure

Response

Related Studies